Thrombotic thrombocytopenic purpura associated with bone marrow metastasis and secondary myelofibrosis in cancer
Chang JC, Naqvi T. Thrombotic thrombocytopenic purpura associated with bone marrow metastasis and secondary myelofibrosis in cancer. The Oncologist 2003;8:375-380.
Thrombotic thrombocytopenic purpura and bone marrow necrosis as a complication of gastric neoplasm
Gonzalez N, Rios E, Martin-Noya A et al. Thrombotic thrombocytopenic purpura and bone marrow necrosis as a complication of gastric neoplasm. Haematologica 2002;87:ECR01.
Breast carcinoma diffusely metastatic to the spleen. A report of two cases presenting as idiopathic thrombocytopenic purpura
Cummings OW, Mazur MT. Breast carcinoma diffusely metastatic to the spleen. A report of two cases presenting as idiopathic thrombocytopenic purpura. Am J Clin Pathol 1992;97:484-489.
Thrombotic thrombocytopenic purpura in metastatic carcinoma of the breast
von Bubnoff N, Sandherr M, Schneller F et al. Thrombotic thrombocytopenic purpura in metastatic carcinoma of the breast. Am J Clin Oncol 2000;23:74-77.
Presence of ADAMST13 activity in a patient with metastatic cancer and thrombotic microangiopathy
Forman RB, Benkel SA, Novik Y et al. Presence of ADAMST13 activity in a patient with metastatic cancer and thrombotic microangiopathy. Acta Haematol 2003;109:150-152.
Microangiopathic haemolytic anaemia in metastasizing malignant tumours is not associated with a severe deficiency of the von Willebrand factor-cleaving protease
Fontana S, Gerritsen HE, Kremer Hovinga J et al. Microangiopathic haemolytic anaemia in metastasizing malignant tumours is not associated with a severe deficiency of the von Willebrand factor-cleaving protease. Br J Haematol 2001;113:100-102.